CUSIP: M53071136
Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Ordinary Shares, no par value
-
Shares outstanding
-
56,557,105
-
Total 13F shares
-
524,803
-
Share change
-
+230,851
-
Total reported value
-
$318,670
-
Price per share
-
$0.61
-
Number of holders
-
19
-
Value change
-
+$120,277
-
Number of buys
-
7
-
Number of sells
-
4
Quarterly Holders Quick Answers
What is CUSIP M53071136?
CUSIP M53071136 identifies ICCM - IceCure Medical Ltd. - Ordinary Shares, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Previous quarter:
Q3 2025
Recent filing periods for CUSIP M53071136:
Institutional Holders of IceCure Medical Ltd. - Ordinary Shares, no par value (ICCM) as of Q4 2025
As of 31 Dec 2025,
IceCure Medical Ltd. - Ordinary Shares, no par value (ICCM) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
524,803 shares.
The largest 10 holders included
JANE STREET GROUP, LLC, UBS Group AG, Concurrent Investment Advisors, LLC, Virtu Financial LLC, GEODE CAPITAL MANAGEMENT, LLC, LPL Financial LLC, TWO SIGMA SECURITIES, LLC, Gunderson Capital Management Inc., HRT FINANCIAL LP, and Wellington Shields Capital Management, LLC.
This page lists
19
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.